Skip to content
ChickenStockChickenStock
ResearchMDWD
Mediwound logo

Mediwound (MDWD) stock

NASDAQ

$12.90-0.54%(-0.07)

As of the Nov 13, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Latest fiscal year

Latest fiscal-year financials · Computed in-house by ChickenStock

P/E

-7.00x

Net loss — not comparable

P/B

3.82x

P/S

9.88x

Latest earnings

SEC filings

Apr–Jun 2025(FY2025 Q2)

No later quarterly filing was found for this company, so this shows the most recent quarter on record.

Revenue increased 20.0% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Aug 14, 2025 · 6-K · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

8 SEC filings
  • Gonen OferChief Executive Officer · Nov 11, 2026Option exercise (expiring)8,168 shares · $110K
    Avg. price $13.47566,019 shares held after
  • SHAMIR NACHUMDirector · Nov 10, 2026Option exercise (expiring)16,336 shares · $220K
    Avg. price $13.47572,151 shares held after
  • Fox David MortonDirector · Nov 10, 2026Option exercise (expiring)6,534 shares · $88K
    Avg. price $13.47528,817 shares held after
  • Rubinstein SamuelDirector · Sep 1, 2026Open-market sale525 shares · $7K
    Avg. price $12.720 shares held after
  • Rubinstein SamuelDirector · Sep 1, 2026Open-market purchase525 shares · $7K
    Avg. price $12.62525 shares held after
  • Hess ShmuelCOO & Chief Commercial Officer · Aug 27, 2026Open-market sale3,958 shares · $51K
    Avg. price $12.9230 shares held after
    Show 2 price lots
    • 1,979 shares × $13.126$26K
    • 1,979 shares × $12.72$25K
  • Hess ShmuelCOO & Chief Commercial Officer · Aug 26, 2026Open-market sale1,865 shares · $24K
    Avg. price $130 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Mediwound (MDWD) stock information

NASDAQ

Mediwound (MDWD) is listed on NASDAQ. Its market capitalization is about $168M. On trailing-twelve-month earnings the P/E ratio is -7, and the P/B ratio is 3.82. Return on equity is -54.5%. These figures are computed in-house from official filings and are reference information only.

Mediwound — frequently asked questions

What is the P/E ratio of Mediwound (MDWD)?
On a trailing-twelve-month basis, MDWD trades at a P/E ratio of -7. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Mediwound?
MDWD has a market capitalization of about $168M. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.